Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71&#x2009;683 Participants Randomized to NOAC Versus Warfarin

Atrial FibrillationThrombosis and Stroke

Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)

Lancet

Dehbi HM, Fischer U, Åsberg S, Milling TJ, Abend S, Ahmed N, Branca M, Davis LA, Engelter ST, Freemantle N, Gattringer T, Ghukasyan Lakic T, Hijazi Z, James M, Koga M, Lawrence P, Lemmens R, Lip GYH, Massingham S, Nash PS, Ndoutoumou A, Norrving B, Salanti G, Sprigg N, Thomalla G, Vanniyasingam T, Wester P, Warach SJ, Oldgren J, Dawson J, Werring DJ

doi: 10.1016/S0140-6736(25)00439-8

Heart, Artery and Coronary DiseasesTherapy and Intervention

Transcatheter or Surgical Treatment of Patients With Aortic Stenosis at Low to Intermediate Risk: An Individual Participant Data Meta-Analysis

JAMA Cardiol

Ludwig S, Klimek M, Bay B, Blankenberg S, Granada JF, Hildick-Smith D, Hudson J, Jørgensen TH, Leon MB, Magnussen C, Thiele H, Hørsted Thyregod HG, Wendler O, de Backer O, Toff WD, Ziegler A, Seiffert M

doi: 10.1001/jamacardio.2025.3403

Heart, Artery and Coronary Diseases

Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis

Lancet

Valgimigli M, Choi KH, Giacoppo D, Gragnano F, Kimura T, Watanabe H, Kim HS, Kang J, Park KW, Pettersen AÅ, Woodward M, Bhatt DL, Calabrò P, Angiolillo DJ, Mehran R, Song YB, Hahn JY

doi: 10.1016/S0140-6736(25)01562-4

Heart, Artery and Coronary DiseasesMyocardial Infarction

Complete versus culprit lesion-only revascularisation for acute myocardial infarction (Complete Revascularisation Trialists' Collaboration): an individual patient data meta-analysis of randomised trials

Lancet

Mehta SR, Tiong DTW, Böhm F, Ramasundarahettige C, Biscaglia S, Campo G, James S, Smits PC, Giacoppo D, McCann GP, Banning A, Høfsten DE, Casella G, Kirabo FR, Nguyen H, Wood DA, Cairns JA, Engstrøm T

doi: 10.1016/S0140-6736(25)02170-1

Atrial Fibrillation

Left atrial appendage occlusion versus NOACs in patients with atrial fibrillation: Rationale and design of the CATALYST Trial

Am Heart J

Reddy VY, Hylek E, Camm AJ, Halperin JL, Diener HC, Thaler D, Schmidt B, Hara H, Huisman MV, Price MJ, Lakkireddy D, Gage R, Zhao H, Jensen TP, Quintana M, Windecker S

doi: 10.1016/j.ahj.2026.107367

Heart, Artery and Coronary Diseases

Diagnostic Performance of Non-Hyperemic Pressure Ratios Versus Fractional Flow Reserve Stratified by Coronary Artery: A Systematic Review and Meta-Analysis of Individual Patient Data

J Am Heart Assoc

Storozhenko T, Collison D, Johnson NP, Sakai K, Mizukami T, Shinke T, Matsuo H, Munhoz D, Buytaert D, Ando H, Ko B, Ihdayhid A, Biscaglia S, Rivero F, Engstrøm T, Arslani K, Leone AM, van Nunen LX, Fearon WF, Christiansen EH, Nørgaard BL, Maeng M, Desta L, Yong A, Otake H, Takahashi Y, Andreini D, Leipsic J, Koo BK, Barbato PM, Bartunek J, Barbato E, Sonck J, De Bruyne B, Collet C

doi: 10.1161/JAHA.124.040916

Atrial Fibrillation

Risk of syncope and permanent pacing with rate versus rhythm control of atrial fibrillation: A systematic review and meta-analysis

Heart Rhythm

Quevillon T, Faridi B, McIntyre WF, Betteridge-LeBlanc S, Little S, Michael F, Parkash R, Andrade J, Ha A, Amit G, Healey JS, Ko DT, Shurrab M

doi: 10.1016/j.hrthm.2025.08.014

Atrial FibrillationTherapy and Intervention

Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical Trial

JAMA Cardiol

Patel SM, Giugliano RP, Morrow DA, Goodrich EL, Murphy SA, Hug B, Parkar S, Chen SA, Goodman SG, Joung B, Kiss RG, Wojakowski W, Weitz JI, Bloomfield D, Sabatine MS, Ruff CT

doi: 10.1001/jamacardio.2025.3393

Heart, Artery and Coronary Diseases

Fractional flow reserve vs angiography to guide percutaneous coronary intervention: an individual patient data meta-analysis

Eur Heart J

Mangiacapra F, Paolucci L, De Bruyne B, Rioufol G, Hahn JY, Chen SL, Koo BK, Tonino PAL, van 't Veer M, Motreff P, Angoulvant D, Lee JM, Hwang D, Yang S, Pijls NHJ, Barbato E, Physiology and Revascularization for Myocardial Endpoints (PRIME) Collaboration

doi: 10.1093/eurheartj/ehaf504

Cardiovascular

Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin

Related content

Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)

Transcatheter or Surgical Treatment of Patients With Aortic Stenosis at Low to Intermediate Risk: An Individual Participant Data Meta-Analysis

Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis

Complete versus culprit lesion-only revascularisation for acute myocardial infarction (Complete Revascularisation Trialists' Collaboration): an individual patient data meta-analysis of randomised trials

Left atrial appendage occlusion versus NOACs in patients with atrial fibrillation: Rationale and design of the CATALYST Trial

Diagnostic Performance of Non-Hyperemic Pressure Ratios Versus Fractional Flow Reserve Stratified by Coronary Artery: A Systematic Review and Meta-Analysis of Individual Patient Data

Risk of syncope and permanent pacing with rate versus rhythm control of atrial fibrillation: A systematic review and meta-analysis

Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical Trial

Fractional flow reserve vs angiography to guide percutaneous coronary intervention: an individual patient data meta-analysis